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Summary: Lactate measurements can be performed within 2-3 minutes after blood withdrawal from the patients
by using an electrochemical enzymatic sensor for lactate. The values obtained reflect the actual state of the patient
which is not the case with the slow classical method using lactate dehydrogenase and NAD.
The sensor is reproducible and the influence of the main reducing substances found in the blood is small enough
to be of no clinical significance. Drugs commonly used in intensive care stations have no influence on the sensor. In
vitro lactate production of the blood cells has been studied under various conditions.
66 pairs of comparative measurements between the classical method and the lactate sensor resulted in a good corre-
lation coefficient.
Schnelle Bestimmung von Lactat mit einem elektrochemisch-enzymatischen Sensor:
Klinische Brauchbarkeit und vergleichende Messungen
Zusammenfassung: Die Lactatbestimmung im Blut innerhalb von 2—3 Minuten nach Blutabnahme wird durch einen
elektrochemisch-enzymatischen Sensor ermöglicht. Die erhaltenen Werte geben den tatsächlichen Zustand des Pa-
tienten wieder, was mit der langsamen, klassischen Methode unter Verwendung von Lactatdehydrogenase und NAD
nicht möglich ist.
Die mit dem Lactatsensor erhaltenen Werte sind reproduzierbar. Der Einfluß der wichtigsten reduzierenden Substan-
zen im Blut ist sehr gering und nicht von klinischer Bedeutung. Medikamente, die in der Intensivpflege oft verwendet
werden, haben keinen Einfluß auf den Sensor. Die in vitro Lactatproduktion der Blutkörperchen wurde unter ver-
schiedenen Bedingungen untersucht.
Es wurden 66 Vergleichsmessungen zwischen der klassischen Methode und dem Lactatsensor durchgeführt. Der Korre-
lationskoeffizient ist gut.
Introduction
Many critically sick patients develop acidosis as a result
of profound respiratory, hemodynamic and/or meta-
bolic abnormalities. Plasma lactate elevations commonly
result from metabolic disturbances producing acidosis
particularly with associated vascular collapse. Measure-
ment of serum or blood lactate would be of great help
in distinguishing lactic acidosis from other causes and
in the following treatment. Even though lactic acidosis
is found in a variety of clinical circumstances, serum
lactate levels are obtained much less frequently than
are the other measurements of the acidotic state such
as pH and carbon dioxide tension.
A combination of problems generally makes the proce-
dure for lactate determination too expensive to perform
regularly for sick patients. Lactate is being formed in
vitro so any delay between drawing the sample, sepa-
rating the red cells and stopping their metabolism will
increase the lactate levels. In most laboratories lactate
is not determined routinely so that even "stat" samples
may be delayed long enough that the results no longer
accurately reflect the patient's state.
Some delay is also unavoidable because of the time re-
quired to perform a single lactate determination. Since
lactate levels are of greatest use for critically ill patients,
the determination must reflect rapidly changing clinical
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conditions and must be compatible with the work
schedules of a busy staff. A technically simple device
which would rapidly measure lactate would solve these
problems, particularly if it were simple enough -to be
actually used by the staff caring for the patient. It is
our purpose to describe our experience with a semi-
automatic device which can be used to determine lac-
tate levels in a clinical setting by personnel not specifi-
cally trained for the task.
Sensor
D. L Williams et al. (4) were the first to report lactate
measurements using an electrochemical enzymatic
sensor. This method was later improved by Ph. Racine
(5, 6, 7) and coworkers. With the device used here,
lactate measurement is based on the specific and
irreversible oxidation of i-lactate to pyruvate in the
presence of an electron acceptor (hexacyanoferrate(III))
and the enzyme cytochrome b2 from baker's yeast
(Saccharomyces cerevisiae):
(Lactate)-1 2Fe(CN)6"3 cytochrome b2 }
2H+ + 2Fe(CN)6-4
The hexacyanoferrate(II) is reoxidized at a platinum
electrode biased at 0.25-0.40 volts against a silver-silver
chloride electrode.
2Fe(CN)6-4 2Fe(CN)6-3 •2e-
Thus in response to the presence of I-lactate, the sensor
develops a current which is linearly related to the ex-
ternal concentration of this substrate.
A scheme of the sensor is shown in figure 1.
It consists of a slightly recessed disc-shaped platinum
electrode covered with a layer of enzyme solution. A
semipermeable cellophane membrane separates the
enzyme layer from the test solution allowing diffusion
of lactate and hexacyanoferrate(III) but preventing
enzyme from leaking into the test solution. As counter
electrode, a silver-silver chloride electrode separated
from the test solution by a glass-frit is used.
' Platinum
electrode
* Enzyme layer
50 to 100jLim thick
^Semiperrneable
membrane
Using membranes made from regenerated cellulose (DU-
PONT PUDO 193) and enzyme solutions of about
2000 kU/1 (at 25 °C) the sensor gives a linear calibra-
tion curve for about 4 weeks in the range 0-1.5 mmol/1.
The response time of a sensor varies initially from 40 se-
counds at the end of its useful life time.
The intrinsic reproducibility of the sensor response is
good, as can be seen from the recordings of its output
current for two different lactate standards (fig. 2). A
deviation not exceeding 1 % is routinely observed
during daily calibrations of the instrument.
When the sensor response ceases to be linear or becomes
too slow due to the inevitable denaturation of the
enzyme, the membrane is discarded and the platinum
surface cleaned by an anoding etching. Fresh enzyme
suspension (1 μΐ) kept in saturated ammonium sulfate
is then placed on the platinum electrode, and a new
membrane is fitted after it has been soaked in bi-distil-
led water for at least one minute. The sensor can thus
be used for several weeks to perform several hundred
lactate assays.
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Fig. 1. Scheine of the lactate sensor
Fig. 2. Recording of the sensor current after the injection of
0.5 (left) and 1.0 (right) mmol/1 lactate standard. »
Instrument and Sample Measurement
A prototype of a semi-automatic Lactate Analyzer has ·
been developed and its functions have been described
in a recent publication (8). In the study reported here,
an earlier laboratory prototype was utilized whose
essential functions do not differ from the latest unit.
The heart of the instrument is a plexiglass measurement
cell containing the sensor and the counter electrode. The
total volume from sample inlet to outlet is 100 μΐ and
the volume between the electrodes (70 μΐ) is thermo- "
stated at 20 °C. Figure 3 is a schematic diagram of the
measurement system and figure 4 a picture of the in-
strument. Emptying and washing of the cell is auto-
matic and the readout is analog. Calibration is performed
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Fig. 3. Schematic diagram of the measurement system
twice daily with a standard of 1.00 mmol/1 by adjusting
the readout on 10.0 mmol/1 with the calibration poten-
tiometer. Linearity is then checked with a standard of
0.50 mmol/1.
Physiological lactate levels can be above 10 mmol/1,
thus the sample is diluted 10 times prior to measure-
ment. A sample of at least 50 μΐ of whole blood is
taken and diluted 10 times with an isotonic phosphate
buffer (pH = 7.3, 0.10 mol/1 + 2 g/1 NaF + 1 g/1 NaN3).
0.50 ml of this diluted sample are injected into the
measurement cell. The same volume of standard is
used for calibration. Between measurements the cell is
rinsed using a solution of 0.2 mol/1 phosphate buffer
(pH = 7.3) containing 2.0 mmol/1 hexacyanoferrate(III).
Method
Sixty-six comparative measurements of blood were used to cal-
culate the correlation between the enzymatic method performed
in the laboratory of the "Medizinische Universit tsklinik, T bin-
gen" and the Lactate Analyzer. The enzymatic spectrophoto-
metric determinations were performed according to the method
offfohorsf (12), which was checked by Linden (13).
The lactate determination with the Lactate Analyzer was per-
formed according to the above method. Immediately after
withdrawal, 100 μΐ whole blood were diluted 10 times with the
isotonic phosphate buffer (0.1 mol/1 pH = 7.3). 0.50 ml of this
diluted sample were injected into the measurement cell using
a disposable 2 mi-syringe. The readout followed between
40-60 seconds. Thereafter and just before the next measure-
ment was started the cell was rinsed with 0.2 mol/1 phosphate
buffer, pH = 7.3, containing 2.0 mmol/1 hsxacyanoferrate(III).
Each sample was determined twice and the mean value is
shown in table 1.
Blood was withdrawn, without heparin addition, from a freely
flowing brachial vein, a femoral artery or from the pulmonary
artery during cardiac cathetcrization. The samples were pro-
cessed immediately. In 7 cases it was not possible to perform
the lactate determination immediately. Five of these were
diluted in phosphate buffer + sodium fluoride (2 g/1) at a ratio
of 1:10 and stored in an ice bath. For two, the blood was he-
parinized and placed in the ice bath immediately. These 7 samp-
les were chemically analyzed between 20 and 60 minutes
following blood withdrawal.
Blood cells continue to produce lactate when citrated or hepa-
rinized blood is allowed to stand at room temperature. Further-
more during a series of preliminary measurements it had been
observed that lactate also rose when diluted blood samples were
left standing at room temperature. To test this observation and
to get an optimum determination of lactate, 10 ml heparinized
blood was taken from 7 subjects. From each sample, 3 ml of
the blood were poured immediately into a second tube. Two
ml of blood were pipetted into a third and fourth tube which
contained 8 ml of 0.1 mol/1 phosphate buffer + 2 g/1 NaF. The
second and fourth tubes were immediately placed into an ice
jg^^^ . Λ^/ \
Fig. 4. Prototype of the Lactate Analyzer
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Tab. 1
No.
1
2
3
4
*T
5
6
7
g
9
10
12
13
14
15
16
17
18
19
20
21
22
23
, Lactate values obtained with the classical method and the Lactate Analyzer
Spectro-
photo-
metric
method
[mmol/1]
1.900
0.900
0.980
1.540
1.180
1.440
1.220
0.880
0.570
0.980
0.860
0.830
1.300
1.200
0.930
1.230
0.670
0.650
0.620
1.150
. 0.630
2.440 ·, \
4.170 .
Lactate Analyzer
[mmol/1]
1.900
1.000
1.200
1.800
0.950
1.100
0.950
0.600
0.450
0.650
0.600
0.600
1.300
0.900
0.800
1.000
0.500
0.500
0.950
1.200
0.650
2.560
4.400
No.
24
25
26
27
28
29
30
31
32
s·
35
36
37
38
39
40
41
42
43
44
45
46
47
Spectro-
photo-
metric
method
[mmol/1]
1.780
0.640
1.920
1.980
0.950
0.610
3.640
2.510
4.470
2.060
7.640
3.890
1.620
1.020
0.870
0.730
0.780
0.720
0.860
0.870
0.850
1.010
0.980
1.120
Lactate Analyzer
[mmol/1]
1.780
0.790
1.900
2.000
0.950
0.850
3.900
2.100
4.250
2.000
7.150
4.050
1.700
0.910
0.880
0.800
0.780
0.720
0.700
0.700
0.800
0.850
0.920
1.000
No.
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
Spectro-
photo-
metric
method
[mmol/1]
0.790
1.150·'
1.000
1.210
0.930
0.920
0.830
0.810
0.790
0.800
0.790
0.880
1.010
1.030 .
1.170
0.740
0.830
0.770
0.760
Lactate
Analyzer
[mmol/1]
0.700
0.950
0.820
1.050
0.800
0.780
0.750
0.700
0.700
0.680
0.690
0.820
0.900
0.900
1.050
0.700
0.780
0.650
0.780
Error in the setting of the dilution ratio
bath. The first and third tubes were kept at room temperature.
The first measurement of lactate was started within 4 minutes
after blood sampling. The lactate concentrations from tubes
1, 2, 3 and 4 were sequentially measured at 3-4 minute inter-
vals until the 72nd minute. Thereafter, measurements were
made at the 80th, 90th, 110th and 120th minute. The dilution
ratio for these measurements was 1:5 (blood: 0.1 mol/1 phos-
phate buffer). Calibrations were made before starting the
measurements, in the 75th minute and after their completion.
All measurements were made with the Lactate Analyzer accor-
ding to the above method.
The reaction catalyzed by cytochrom b2 is specific for Z,-lac-
tate, but other substrates can react with reduced efficiency
(9, 10). The most active are α-hydroxy-H-butyrate, a-hydroxy-
τί-caproate and α-hydroxy-isocaproate. Only -hydroxy-Λ-
butyrate is encountered in blood where it reaches concentra-
tions of 10 mmol/1 in diabetic patients. To test this, 0.1, 1.0
and 10 mmol/1 0-hydroxy-/i-butyrate (Merck) were prepared in
a 0.1 mol/1 phosphate buffer at pH of 7.3. These were com-
pared with a 1.0 mmol/1 lactate standard prepared in the same
buffer.
It has been reported (6) that blood reducing substances are
capable of either reducing the acceptor, hexacyanof errate (ill)
or being oxidized at the platinum electrode. Some of these
substances were added to the 10 mmol/1 lactate standard and
the resulting changes determined. These are shown in table 4.
Low concentrations of certain drugs can act as inhibitors or
activators of enzyme activity. Drugs often prescribed for
critically ill patients were tested using a 1.0 mmol/1 lactate stan-
dard to which the drug was added. Table 5 shows the concentra-
tions of these drugs.
Results
All comparative measurements are given in table 1.
Table 2 shows the correlation coefficient and the re-
Tab. 2. Correlation coefficient for the comparative measure-
ments
Number of measurements pair
Correlation coefficient
Regression line
- Intercept a0
- Slope aj
66
0.990
- 0.055 ±0.032
0.988 ±0.018
gression equation for these values. There is a good
correlation (r = 0.990). Figure 5 shows the regression
line with the 95% confidence level for the data points.
The results of incubation measurements are given in
table 3 and plotted on figure 6. The mean percent in-
crease ± the standard deviation from the first measure-
ment is shown for the 7 samples. The initial lactate
values were between 0.6 and 2.0 mmol/1. The results
show that there is a continuous and nearly linear in-
crease in lactate concentration when heparinized. blood
is stored at room temperature. However, if heparinized
whole blood is placed in an ice bath, there is no increase
in lactate concentration over 120 minutes.
Blood diluted with buffer containing NaF and stored at
room temperature showed an initial increase in measured
lactate. This increase was more rapid than the increase
observed in undiluted blood during that period of time
(p < 0.05). The rapid increase in apparent lactate level
stops after 20—30 minutes. When heparinized blood
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Tab. 3, In viuo effect of temperature and dilution in NaF containing buffer OB blood tectate level*
Heparinized whole blood at room temperature (23 *Cj
Diluted Hood at room temperature
11
24
37
51
65
87
117
2l. 8 t 8.77
27.9t 8.06
30.9 1 10.03
31. 0 ± 8.27
32.4 ± 9.7
33.7 i 9.0
36.5 i 9.2
2p < 0.001
2p
2p
2p
2p
2p
2p
Heparinaed whole blood in ice bath
Incubation Lactate increase
time (%)
[mini x t s
17
32
43
57
SO
no
13.8± 3.74
20.6 t 4.33
31.5*11.9
45.5 t 21.9
61.0*22.8
89.9 t 32.4
Significance
level
2 p < 0.00l
2p
2p
2p
2p
2p
Incubation Lactate increase
time (5£)
(mtn| χ t *
7
21
34
48
61
M
114
-4.8 ±8.53
- 4.8 ± 8.53
- 3.3 ± 6.07
- 2.1 t 5.4
- 1.3 r 5.9
+ 0.1 r 7.2
1.9 = 5.9
Significance
level
2 p <
2p
2p
2p
2p
2p
2p
0.2
Diluted blood in ice bath
14
28
40
M
68
90
121
-0.6 τ 1.8
0 ± 0
0 ± 0
0 ± 0
0 t 0
0 *0
0 ± 0
2 p <
-
-
-
~
-
-
0.5
iS"
l 2
15
05 1 15 l 25 3 35
59 70 SO HO 130
t lern J
Fig. 5. Regression line for the correlation between the values of ***§· 6. Change of lactate concentration over 120 minutes in
the Lactate Analyzer and the spectiophotometric method whole and diluted blood at room temperature and on ice
ο ο whole blood at 25 CC
x χ whole blood on ice
• · diluted blood at 25 *C
A A diluted blood on ice
regression line
95 % confidence level data points
was diluted with NaF containing buffer and stored in an
ice bath, no change in lactate level was noted.
Table 4 shows the effect various reducing substances in
the blood have on the measured lactate level It can be
seen that l L9 mmol/1 of uric acid increases the measured
lactate level to 0.3 mmol/L The other reducing substan-
ces showed smaller and clinically negligible effects. A
slight diminution in apparent lactate levels occurs with
some substances Uke cysteine, whereas when /^lactate
is not present a small increase in current occurs which
could be read as lactate. Table S shows that none of the
drugs tested caused a change in the lactate reading. 0-
hydroxy-n-butyrate at concentrations ofQA, 1,0 and
10 mmol/1 showed 00 effect.
Tab. 4. Effect of various blood reducing substances on
the reading of the lactate sensor
Substance
Ascorbic acid
0-Alanine
Creatinine
Cyrtine
Gtycine
GSH
urea
Uric acid
Salicylate
Adrenaline
Normal blood
level
ί mmol/1 }
0.04-0.14
0.45
0.04
0.08
0.27
1.14
3.33
0.18-0.36
?
0.0014
Concentration
U!£d
(mmoi/lj
0.14
0.56
0.44
0,08
0.67
1.30
9.99
1.19
2.Π
0.014
Apparent
change
J mmol/1 J
0
0
-0.15
-0.1
-0.05
0
0
+ 0.3
0
0
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Tab. 5. Influence of commonly used drugs in intensive care
stations
Active substance
Lanatosid C
Eraldin
p-Amino N 2 diethyl-
aminoethylbenzamide HC1
Propanolol
Lidocaine
Diphenylhydantoin Na
Concentration
[mg/1]
0.13
2
170
4
200
10
Change' in
sensor reading
[mmol/1]
0
0
0
0
0
0
Discussion
The blood handling tests indicate that at room tempera-
ture there is a continuous increase in the lactate concen-
tration of whole blood over the observation time of
120 minutes. The lactate increase is due to continued
lactate production by blood cells. When samples are
placed in an ice bath, the metabolic processes are
blocked and lactate production stops.
/. 0. Westgard et al. (11) have shown that the lactate
concentration is stable when whole blood is mixed with
a sodium fluoride solution (2 g NaF/1) and centrifuged
within 15 minutes after blood collection. They reported
that whole blood containing NaF and stored at room
temperature increased its lactate to 0.068 mmol/1 in
the first 15 minutes after sampling. Following 14 days
of storage at 4 °C, there was a minimal increase of
0.026 mmol/1 in the centrifuged samples. Their data
indicated that the increase of lactate was due to con-
tinued lactate production by the blood cells in the first
15 minutes after blood collection.
In our tests, however, this effect is much less pro-
nounced in diluted, not centrifuged, blood stored at
room temperature. After a steep initial increase the
curve for this series (fig. 6) levels off and shows no
further marked lactate production during the next
90 minutes. The increase up to the plateau is, on the
average, 30% above the initial value in the concentra-
tion range 0.6-2.0 mmol/1. The stabilizing feffect of
the NaF is visible in phase 2 of the curve but it does
not prevent the fast initial increase. The utilization of
NaF alone as a stabilizing agent is not sufficient in
this particular situation.
Lactate concentration does not change if heparinized
whole blood is diluted immediately after sampling with
0.1 mol/1 phosphate buffer pH = 7.3 + 2 g/1 NaF at a
ratio of 1:5 (or 1:10) and the diluted blood is immedia-
tely placed in an ice bath. There were no deviations
from the initial value in all 7 samples treated in this
manner over the entire observation time of 2 hours.
This interval should be sufficient for the daily routine
application where it is not always possible to determine
lactate immediately after sample collection.
The following practical possibilities exist for the opti-
mum determination of lactate:
1. Heparinized whole blood'should be diluted with
buffer immediately after sampling arid the lactate
determined with the Lactate Analyzer without
delay (< 3 minutes).
2. If'it is not possible to determine the lactate imme-
diately after sampling, one can either:
a) extend the time between blood withdrawal and
measurement to at least 90 minutes by placing
immediately the heparinized sample in an ice bath.
In this manner no significant changes will be ob-
served.
b) Dilute the sample with the appropriate buffer and
place it also immediately in an ice bath. No change
in lactate concentration will be observed at least for
the next 120 minutes.
With the exception of unusually high levels of uric
acid, none of the reducing substances found in blood
interfere with the enzyme reaction used. Even the
uric acid effect is minimal at commonly encountered
uric acid levels. The drugs tested did not cause an
effect. Drugs which potentiate or inhibit enzyme
acitivity are a potential source of erroneous results.
However, none has been found by us among drugs
commonly used in situations where lactate determi-
nations would be of clinical interest. Drug therapy
might also affect the usable lifetime of the sensor
without affecting the lactate results. This would be
particularly true of drugs containing heavy metals
such as mercury.
The Lactate Analyzer permits lactate determinations
within 2-3 minutes of the time when blood is drawn.
This is a decisive advantage for critically ill patients. The
luxury of a rapid result is not possible with the spectro-
photometric method since the classical method re-
quires ΐγ2 to 2 hours. However, certain automatic
discrete sample analyzers now becoming available in
large clinical laboratories require about the same amount
of time per analysis as does this single purpose analyzer.
A large discrete sample analyzer would not be as satis-
factory as the lactate analyzer since it could not be
placed in the patient area, thus producing a time delay
between sampling and analysis whiph could cause an
increase in lactate level.
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